<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "http://dtd.nlm.nih.gov/publishing/2.0/journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="2.0" xml:lang="EN">
  <front>    <journal-meta>
      <journal-title>Scientific Research and Essays</journal-title>
      <issn pub-type="epub">1992-2248</issn>      <publisher>
        <publisher-name>Academic Journals</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.5897/SRE2019.6604</article-id>
      <title-group>
        <article-title><![CDATA[Nanomedicines: Challenges and perspectives for future nanotechnology in the healthcare system]]></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
        		        	<name name-style="western">
	            <surname>Ajazuddin</surname>
            <given-names></given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Sabahuddin</surname>
            <given-names>Siddique</given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Amit</surname>
            <given-names>Alexander</given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Pooja</surname>
            <given-names>Yadav</given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Mukta</surname>
            <given-names>Agrawal</given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Ahmed</surname>
            <given-names>M Shehata</given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Mahmoud</surname>
            <given-names>A Shaker</given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Syed</surname>
            <given-names>Ata Ur Rahman</given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Mohi</surname>
            <given-names>Iqbal M Abdul</given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Mohamed</surname>
            <given-names>A. Shaker</given-names>
	          </name>	
        	        </contrib>
      </contrib-group>
      <author-notes>
		<corresp id="cor1">* E-mail: <email xlink:type="simple">drmdshaker2019@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2019</year>
      </pub-date>
      <pub-date pub-type="epub">
      	<day>15</day>
        <month>04</month>
        <year>2019</year>
      </pub-date>
      <history>
      			<date date-type="received">
			<day>01</day>
			<month>02</month>
			<year>2019</year>
		</date>
						<date date-type="accepted">
			<day>29</day>
			<month>03</month>
			<year>2019</year>
		</date>
			  </history>
      <volume>14</volume>
      <issue>5</issue>
	  	  <fpage>32</fpage>
	  <lpage>38</lpage>
      <permissions>
		<license xlink:type="simple">
			<license-p>
			This is an open-access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
			</license-p>
		</license>
	  </permissions>
	  <self-uri xlink:href="http://politicalwaffle.uk/journal/SRE/article-abstract/60E390860778">
		This article is available from http://politicalwaffle.uk/journal/SRE/article-abstract/60E390860778	  </self-uri>
	  <self-uri xlink:href="http://politicalwaffle.uk/journal/SRE/article-full-text-pdf/60E390860778">
		The full text article is available as a PDF file from http://politicalwaffle.uk/journal/SRE/article-full-text-pdf/60E390860778	  </self-uri>
	  
      <abstract><![CDATA[A novel approach of combining nanotechnology to the pharmaceutical and biotechnological field resulted in the formation of nanomedicines. Nanomedicines have progressed to a more considerable extent for curing irremediable diseases such as neurological defects, cardiovascular defects, etc., because of its minute size which assists in increased surface area and hence a remarkable dissolution profile. In addition to the health care sector, modernization of nanotechnology has also been implemented in other industries like cosmetics, electronics, catalysis, and chemical industries. Nanoparticles can be made by using polymers, either lipids or inorganic compounds like metals. They can be prepared by using either top to bottom or bottom to top approach. Interestingly, polymeric nanoparticles have provided an enormous opportunity to alter the surface of the nanoparticles leading to better drug delivery and drug targeting. However, these have the potential to induce toxicity as well. Also, the toxicity profile still has to be investigated. Moreover, characterization of the nanomedicines is always trouble, which has created a gap between conventional drugs and nanomedicines.

	Key words: Nanomedicines, polymeric nanoparticles, lipid nanoparticle, drug targeting, nanotoxicology.]]></abstract>
    </article-meta>
  </front>
      <body/>
    <back>
		<ref-list>
			<title>References</title>
						<ref id="ref1">
				<label>1</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Abeer S (2012). Future medicine: Nanomedicine. JIMSA 25(3):187-192.]]>
				</mixed-citation>
			</ref>
						<ref id="ref2">
				<label>2</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Chougule MB, Shoyele SA, Alexander A (2018a). Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-alzheimer drugs. Journal of Controlled Release 281:139-177.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref3">
				<label>3</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Hamano N, Li SD, Chougule M, Shoyele SA, Gupta U, Ajazuddin, Alexander A (2018b). Recent advancements in the field of nanotechnology for the delivery of anti-alzheimer drug in the brain region. Expert opinion on drug delivery 15(6):589-617.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref4">
				<label>4</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Ahamed M (2011). Toxic response of nickel nanoparticles in human lung epithelial a549 cells. Toxicology in Vitro 25(4):930-936.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref5">
				<label>5</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Akhter S, Ahmad I, Ahmad MZ, Ramazani F, Singh A, Rahman Z, Ahmad FJ, Storm G, Kok RJ (2013). Nanomedicines as cancer therapeutics: Current status. Current Cancer Drug Targets 13(4):362-378.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref6">
				<label>6</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Alexander A, Saraf S, Agrawal M, Patel R, Agrawal P, Khan J (2018). Amalgamation of stem cells with nanotechnology: A unique therapeutic approach. Current Stem Cell Research and Therapy.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref7">
				<label>7</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Antimisiaris SG, Mourtas S, Markoutsa E, Skouras A, Papadia K (2014). Nanoparticles for diagnosis and/or treatment of alzheimers disease. In: Advanced healthcare materials. John Wiley  Sons, Inc., pp. 87-179.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref8">
				<label>8</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Arora P, Sindhu A, Dilbaghi N, Chaudhury A, Rajakumar G, Rahuman AA (2012). Nano-regenerative medicine towards clinical outcome of stem cell and tissue engineering in humans. Journal of Cellular and Molecular Medicine 16(9):1991-2000.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref9">
				<label>9</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Aschengrau ASG (2008). Essentials of epidemiology in public health. MA: Jones and Bartlett Publishers.]]>
				</mixed-citation>
			</ref>
						<ref id="ref10">
				<label>10</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Bobo D, Robinson KJ, Islam J, Thurecht KJ, Corrie SR (2016). Nanoparticle-based medicines: A review of fda-approved materials and clinical trials to date. Pharmaceutical Research 33(10):2373-2387.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref11">
				<label>11</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Bouck N, Stellmach V, Hsu SC (1996). How tumors become angiogenic. Advances in Cancer Research 69:135-174.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref12">
				<label>12</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Brand W, Noorlander CW, Giannakou C, De Jong WH, MW Kooi, MV Park, RJ Vandebriel, IE Bosselaers, JH Scholl, RE Geertsma (2017). Nanomedicinal products: A survey on specific toxicity and side effects. International Journal of Nanomedicine, 12:6107-6129.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref13">
				<label>13</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Cerrillo C, Barandika G, Igartua A, Areitioaurtena O, Mendoza G (2017). Key challenges for nanotechnology: Standardization of ecotoxicity testing. Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis and Ecotoxicology Reviews 35(2):104-126.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref14">
				<label>14</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Chen D, Love KT, Chen Y, Eltoukhy AA, Kastrup C, Sahay G, Jeon A, Dong Y, Whitehead KA, Anderson DG (2012). Rapid discovery of potent sirna-containing lipid nanoparticles enabled by controlled microfluidic formulation. Journal of the American Chemical Society 134(16):6948-6951.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref15">
				<label>15</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Ciappellano SG, Tedesco E, Venturini M, Benetti F (2016). In vitro toxicity assessment of oral nanocarriers. Advanced drug delivery reviews 106(Pt B):381-401.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref16">
				<label>16</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Costa C, Brandao F, Bessa MJ, Costa S, Valdiglesias V, Kilic G, Fernandez-Bertolez N, Quaresma P, Pereira E, Pasaro E, Laffon B, Teixeira JP (2016). In vitro cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests. Journal of Applied Toxicology 36(3):361-372.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref17">
				<label>17</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB (2008). The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metabolism 7(1):11-20.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref18">
				<label>18</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Devatha CP, Jagadeesh K, Patil M (2018). Effect of green synthesized iron nanoparticles by azardirachta indica in different proportions on antibacterial activity. Environmental Nanotechnology, Monitoring and Management 9:85-94.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref19">
				<label>19</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Dhawan A, Sharma V (2010). Toxicity assessment of nanomaterials: Methods and challenges. Analytical and Bioanalytical Chemistry 398(2):589-605.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref20">
				<label>20</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Dobrovolskaia MA, Neun BW, Clogston JD, Ding H, Ljubimova J, McNeil SE (2010). Ambiguities in applying traditional limulus amebocyte lysate tests to quantify endotoxin in nanoparticle formulations. Nanomedicine (London, England) 5(4):555-562.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref21">
				<label>21</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Dvir T, Timko BP, Brigham MD, Naik SR, Karajanagi SS, Levy O, Jin H, Parker KK, Langer R, Kohane DS (2011). Nanowired three-dimensional cardiac patches. Nature Nanotechnology 6(11):720-725.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref22">
				<label>22</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Escamilla-Rivera V, Uribe-Ramirez M, Gonzalez-Pozos S, Lozano O, Lucas S, De Vizcaya-Ruiz A (2016). Protein corona acts as a protective shield against fe3o4-peg inflammation and ros-induced toxicity in human macrophages. Toxicology Letters 240(1):172-184.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref23">
				<label>23</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J (2013). The big picture on nanomedicine: The state of investigational and approved nanomedicine products. Nanomedicine: Nanotechnology, Biology and Medicine 9(1):1-14.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref24">
				<label>24</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Fabian E, Landsiedel R, Ma-Hock L, Wiench K, Wohlleben W, van Ravenzwaay B (2008). Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Archives of toxicology 82(3):151-157.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref25">
				<label>25</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Feng L, XR Qi, XJ Zhou, Y Maitani, Wang SC, Jiang Y, Nagai T (2006).]]>
				</mixed-citation>
			</ref>
						<ref id="ref26">
				<label>26</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Pharmaceutical and immunological evaluation of a single-dose hepatitis b vaccine using plga microspheres. Journal of controlled release: Official Journal of the Controlled Release Society 112(1):35-42.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref27">
				<label>27</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Han Y-g, Xu J, Li Z-g, Ren G-g, Z Yang (2012). In vitro toxicity of multi-walled carbon nanotubes in c6 rat glioma cells. NeuroToxicology 33(5):1128-1134.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref28">
				<label>28</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Havel H, Finch G, Strode P, Wolfgang M, Zale S, Bobe I, Youssoufian H, Peterson M, Liu M (2016). Nanomedicines: From bench to bedside and beyond. The AAPS Journal 18(6):1373-1378.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref29">
				<label>29</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Hu Y, Fine DH, Tasciotti E, Bouamrani A, Ferrari M (2011). Nanodevices in diagnostics. Wiley interdisciplinary reviews. Nanomedicine and Nanobiotechnology 3(1):11-32.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref30">
				<label>30</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Iqbal J, Abbasi BA, Ahmad R, Mahmood T, Ali B, Khalil AT, Kanwal S, Shah SA, Alam MM, Badshah H, Munir A (2018). Nanomedicines for developing cancer nanotherapeutics: From benchtop to bedside and beyond. Applied Microbiology and Biotechnology 102(22):9449-9470.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref31">
				<label>31</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Karnik R, Gu F, Basto P, Cannizzaro C, Dean L, Kyei-Manu W, Langer R, Farokhzad OC (2008). Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano letters 8(9):2906-2912.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref32">
				<label>32</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Kaur IP, Kakkar V, Deol PK, Yadav M, Singh M Sharma I (2014). Issues and concerns in nanotech product development and its commercialization. Journal of controlled release Official Journal of the Controlled Release Society 193:51-62.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref33">
				<label>33</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Khan MI, Mohammad A, Patil G, Naqvi SA, Chauhan LK, Ahmad I (2012). Induction of ros, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles. Biomaterials 33(5):1477-1488.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref34">
				<label>34</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Khare S, Alexander A, Amit N (2014). Biomedical applications of nanobiotechnology for drug design, delivery and diagnostics. Research Journal of Pharmacy and Technology 7(8):8.]]>
				</mixed-citation>
			</ref>
						<ref id="ref35">
				<label>35</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Khorasani AA, Weaver JL, Salvador-Morales C (2014). Closing the gap: Accelerating the translational process in nanomedicine by proposing standardized characterization techniques. International Journal of Nanomedicine 9:5729-5751.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref36">
				<label>36</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Kim Y, Lee CB, Ma M, Mulder WJ, Fayad ZA, Farokhzad OC, Langer R (2012). Mass production and size control of lipid-polymer hybrid nanoparticles through controlled microvortices. Nano letters, 12(7): 3587-3591. DOI 10.1021/nl301253v.
					https://doi.org/10.1021/nl301253v]]>
				</mixed-citation>
			</ref>
						<ref id="ref37">
				<label>37</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Kroll, A., M.H. Pillukat, D. Hahn, J. Schnekenburger (2009). Current in vitro methods in nanoparticle risk assessment: Limitations and challenges. European Journal of Pharmaceutics and Biopharmaceutics, 72(2): 370-377.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref38">
				<label>38</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Kroll, A., M.H. Pillukat, D. Hahn, J. Schnekenburger (2012). Interference of engineered nanoparticles with in vitro toxicity assays. Archives of toxicology, 86(7): 1123-1136. DOI 10.1007/s00204-012-0837-z.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref39">
				<label>39</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Kumar H, Gothwal A, Khan I, Nakhate KT, Alexander A, Singh V, Gupta U (2017). Galactose-anchored gelatin nanoparticles for primaquine delivery and improved pharmacokinetics: A biodegradable and safe approach for effective antiplasmodial activity against p. Falciparum 3d7 and in vivo hepatocyte targeting. Molecular pharmaceutics, 14(10):3356-3369.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref40">
				<label>40</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Linkov I, Satterstrom FK, Corey LM (2008). Nanotoxicology and nanomedicine: Making hard decisions. Nanomedicine: Nanotechnology, Biology and Medicine 4(2):167-171.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref41">
				<label>41</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Liu H, Ma L, Zhao J, Liu J, Yan J, Ruan J, Hong F (2009). Biochemical toxicity of nano-anatase tio2 particles in mice. Biological trace element research 129(1-3):170-180.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref42">
				<label>42</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Lozano O, Laloy J, Alpan L, Mejia J, Rolin S, Toussaint O, Dogne JM, Lucas S, Masereel B (2012a). Effects of sic nanoparticles orally administered in a rat model: Biodistribution, toxicity and elemental composition changes in feces and organs. Toxicology and Applied Pharmacology 264(2):232-245.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref43">
				<label>43</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Lozano O, Mejia J, Masereel B, Toussaint O, Lison D, Lucas S (2012b). Development of a pixe analysis method for the determination of the biopersistence of sic and tic nanoparticles in rat lungs. Nanotoxicology 6(3):263-271.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref44">
				<label>44</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Lv H, Zhang S, Wang B, Cui S, Yan J (2006). Toxicity of cationic lipids and cationic polymers in gene delivery. Journal of Controlled Release: Official Journal of the Controlled Release Society 114(1):100-109.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref45">
				<label>45</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Maniam G, Mai CW, Zulkefeli M, Dufes C, Tan DM, Fu JY (2018). Challenges and opportunities of nanotechnology as delivery platform for tocotrienols in cancer therapy. Frontiers in Pharmacology 9:1358.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref46">
				<label>46</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Maynard AD, Warheit DB, Philbert MA (2011). The new toxicology of sophisticated materials: Nanotoxicology and beyond. Toxicological Sciences 120(Suppl 1):S109-129.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref47">
				<label>47</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Mulhopt S, Diabate S (2018). Characterization of nanoparticle batch-to-batch variability. Nanomaterials 8(5):311.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref48">
				<label>48</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Oberdorster G (2010). Safety assessment for nanotechnology and nanomedicine: Concepts of nanotoxicology. Journal of Internal Medicine 267(1):89-105.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref49">
				<label>49</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H (2005). Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Particle and Fibre Toxicology 2:8.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref50">
				<label>50</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Oostingh GJ, Casals E, Italiani P, Colognato R, Stritzinger R, Ponti J, Pfaller T, Kohl Y, Ooms D, Favilli F, Leppens H, Lucchesi D, Rossi F, Nelissen I, Thielecke H, Puntes VF, Duschl A, Boraschi D (2011). Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects. Particle and Fibre Toxicology 8(1):8.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref51">
				<label>51</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Park EJ, Lee GH, Shim HW, Kim JH, Cho MH, Kim DW (2014). Comparison of toxicity of different nanorod-type tio2 polymorphs in vivo and in vitro. Journal of applied toxicology. Journal of AT 34(4):357-366.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref52">
				<label>52</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Pautler M, Brenner S (2010). Nanomedicine: Promises and challenges for the future of public health. International Journal of Nanomedicine 5:803-809.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref53">
				<label>53</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Powell JJ, Faria N, Thomas-McKay E, Pele LC (2010). Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. Journal of Autoimmunity 34(3):J226-233.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref54">
				<label>54</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Pradhan M, Alexander A, Singh MR, Singh D, Saraf S, Saraf S (2018). Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomedicine and Pharmacotherapy 107:447-463.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref55">
				<label>55</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Resnik DB, Tinkle SS (2007). Ethical issues in clinical trials involving nanomedicine. Contemporary Clinical Trials 28(4):433-441.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref56">
				<label>56</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Rhee M, Valencia PM, Rodriguez MI, Langer R, Farokhzad OC, Karnik R (2011). Synthesis of size-tunable polymeric nanoparticles enabled by 3d hydrodynamic flow focusing in single-layer microchannels. Advanced materials (Deerfield Beach, Fla.). 23(12):H79-83.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref57">
				<label>57</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Saraf S, Gupta A, Alexander A, Khan J, Jangde M, Saraf S (2015). Advancements and avenues in nanophytomedicines for better pharmacological responses. Journal of Nanoscience and Nanotechnology 15(6):4070-4079.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref58">
				<label>58</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Shi J, Kantoff PW, Wooster R, Farokhzad OC (2017). Cancer nanomedicine: Progress, challenges and opportunities. Nature reviews. Cancer 17(1):20-37.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref59">
				<label>59</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Spagnou S, Miller AD, Keller M (2004). Lipidic carriers of sirna: Differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry 43(42):13348-13356.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref60">
				<label>60</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Tran S, DeGiovanni PJ, Piel B, Rai P (2017). Cancer nanomedicine: A review of recent success in drug delivery. Clinical and Translational Medicine 6(1):44.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref61">
				<label>61</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Ventola CL (2012). The nanomedicine revolution: Part 1: Emerging concepts. Pharmacy and Therapeutics 37(9):512-525.]]>
				</mixed-citation>
			</ref>
						<ref id="ref62">
				<label>62</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Verma C, Janghel A, Deo S, Raut P, Bhosle D, Kumar SS, Agrawal M, Amit N, Sharma M, Giri T (2015). A comprehensive advancement on nanomedicines along with its various biomedical applications. Research Journal of Pharmacy and Technology 8(7):945-957.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref63">
				<label>63</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Wei A, Mehtala JG, Patri AK (2012). Challenges and opportunities in the advancement of nanomedicines. Journal of Controlled Release 164(2):236-246.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref64">
				<label>64</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Wolfram J, Zhu M, Yang Y, Shen J, Gentile E, Paolino D, Fresta M, Nie G, Chen C, Shen H, Ferrari M, Zhao Y (2015). Safety of nanoparticles in medicine. Current Drug Targets 16(14):1671-1681.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref65">
				<label>65</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Xu J, Xu P, Li Z, Huang J, Yang Z (2012). Oxidative stress and apoptosis induced by hydroxyapatite nanoparticles in c6 cells. Journal of Biomedical Materials Research Part A 100(3):738-745.
					]]>
				</mixed-citation>
			</ref>
						<ref id="ref66">
				<label>66</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Zhang X, Li W, Yang Z (2015). Toxicology of nanosized titanium dioxide: An update. Archives of Toxicology 89(12):2207-2217.
					]]>
				</mixed-citation>
			</ref>
					</ref-list>
	</back>
    </article>